Trial Details
COMPLETEDBasic Information
| Clinical ID | c860 |
|---|---|
| Identifier | NCT05923892 |
| Trial Title | Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome of Diarrhea Type (IBS-D) |
| Interventions | DRUG: OPS-2071|DRUG: placebo |
Participant Information
| Sponsor | Otsuka Beijing Research Institute |
|---|---|
| City | Hubei |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-08-02 |
|---|---|
| Primary Completion Date | 2024-08-01 |
| Completion Date | 2024-08-01 |